Shanghai MicuRx Pharmaceutical Co., Ltd. (SHSE: 688373)
Health Care · Biotechnology · CN
CN¥5.73
-0.87% today · -30.4% 1Y
Shanghai MicuRx Pharmaceutical Co., Ltd. (SHSE: 688373) operates in the Biotechnology industry within the Health Care sector. The company is valued at $561.38M.
Over the last twelve months the share price has lost 30.4%, trading between 4.09 and 9.51.
Tweenvest scores Shanghai MicuRx Pharmaceutical Co., Ltd. across four factors: quality 36/100, value 65/100. Its strongest factor is value.
688373 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $561.38M
- Revenue (TTM)
- $24.19M
- P/E
- —
- EPS
- -0.22
- Dividend yield
- —
- Beta (5Y)
- 0.41
- 52-week high
- CN¥9.51
- 52-week low
- CN¥4.09
- Avg volume (3M)
- —
- Shares outstanding
- 656.23M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Landfar Bio-medicine Co., LtdSZSE: 000504 | $580.91M | CN¥11.79 | -5.07% |
| Guangdong Hybribio Biotech Co.,Ltd.SZSE: 300639 | $575.67M | CN¥6.14 | -2.07% |
| Pharmicell Co., Ltd.KOSE: A005690 | $573.98M | ₩12,860.00 | +3.71% |
| Shanghai Serum Bio-Technology Co., Ltd.SHSE: 688163 | $563.39M | CN¥34.87 | -12.83% |
| Zhejiang Orient Gene Biotech Co., LtdSHSE: 688298 | $557.20M | CN¥19.50 | +0.67% |
| DBV Technologies S.A.ENXTPA: DBV | $555.98M | €1.68 | -11.87% |
| Jacobio Pharmaceuticals Group Co., Ltd.SEHK: 1167 | $555.24M | HK$5.57 | -7.40% |
| Jiangsu Sihuan Bioengineering Co., LtdSZSE: 000518 | $553.35M | CN¥3.60 | +0.28% |
Figures last refreshed Oct 11, 2026.